|
US5116742A
(en)
|
1986-12-03 |
1992-05-26 |
University Patents, Inc. |
RNA ribozyme restriction endoribonucleases and methods
|
|
US4987071A
(en)
|
1986-12-03 |
1991-01-22 |
University Patents, Inc. |
RNA ribozyme polymerases, dephosphorylases, restriction endoribonucleases and methods
|
|
CA2065346C
(en)
|
1989-09-05 |
2005-03-29 |
Craig A. Smith |
Tumor necrosis factor-.alpha. and-.beta. receptors
|
|
CA2085297A1
(en)
|
1991-12-20 |
1993-06-21 |
James Edward Ray |
Sulfonimidamides
|
|
US5705398A
(en)
|
1994-03-02 |
1998-01-06 |
The Scripps Research Institute |
Methods for identifying inhibitors of LPS-mediated LBP binding
|
|
US6090382A
(en)
|
1996-02-09 |
2000-07-18 |
Basf Aktiengesellschaft |
Human antibodies that bind human TNFα
|
|
ATE239041T1
(de)
|
1996-02-09 |
2003-05-15 |
Basf Ag |
Humane antikörper welche an humanen tnfalpha binden
|
|
PL344004A1
(en)
*
|
1998-05-05 |
2001-09-10 |
Hoffmann La Roche |
Pyrazole derivatives as p-38 map kinase inhibitors
|
|
CN1832928B
(zh)
*
|
2003-06-26 |
2012-07-04 |
诺瓦提斯公司 |
以5元杂环为基础的p38激酶抑制剂
|
|
US20080280910A1
(en)
*
|
2007-03-22 |
2008-11-13 |
Keith Allan Menear |
Phthalazinone derivatives
|
|
US8884006B2
(en)
|
2011-09-19 |
2014-11-11 |
University Of Puerto Rico |
Small-molecule inhibitors of Rac1 in metastatic breast cancer
|
|
US9701689B2
(en)
|
2012-11-30 |
2017-07-11 |
Kyowa Hakko Kirin Co., Ltd. |
Substituted pyridines and pyridazines as CCR10 receptor inhibitors
|
|
ITMI20131658A1
(it)
|
2013-10-08 |
2015-04-09 |
Getters Spa |
Combinazione di materiali per dispositivi di rilascio di mercurio e dispositivi contenenti detta combinazione di materiali
|
|
US9714288B2
(en)
|
2014-09-30 |
2017-07-25 |
The Regents Of The University Of California |
Antisense compounds and uses thereof
|
|
JP6929792B2
(ja)
*
|
2015-02-16 |
2021-09-01 |
ザ ユニバーシティ オブ クィーンズランド |
スルホニル尿素及び関連化合物並びにその使用
|
|
BR112018008506B8
(pt)
*
|
2015-10-29 |
2023-12-05 |
Merck Sharp & Dohme |
Compostos inibidores do fator xia, composição farmacêutica e usos dos mesmos
|
|
FR3046933B1
(fr)
*
|
2016-01-25 |
2018-03-02 |
Galderma Research & Development |
Inhibiteurs nlrp3 pour le traitement des pathologies cutanees inflammatoires
|
|
US11447460B2
(en)
*
|
2016-04-18 |
2022-09-20 |
Novartis Ag |
Compounds and compositions for treating conditions associated with NLRP activity
|
|
MA44729A
(fr)
*
|
2016-04-18 |
2021-05-12 |
Novartis Ag |
Composés et compositions pour traiter des états associés à une activité de nlrp
|
|
EP3445761A1
(en)
|
2016-04-19 |
2019-02-27 |
Innate Tumor Immunity, Inc. |
Nlrp3 modulators
|
|
KR102521955B1
(ko)
*
|
2016-06-14 |
2023-04-13 |
브리스톨-마이어스 스큅 컴퍼니 |
Apj 수용체 효능제로서의 4-히드록시-3-술포닐피리딘-2(1h)-온
|
|
UA126675C2
(uk)
|
2017-01-23 |
2023-01-11 |
Дженентек, Інк. |
Хімічні сполуки як інгібітори активності інтерлейкіну-1
|
|
EP3634951B8
(en)
|
2017-06-09 |
2024-08-21 |
Zydus Lifesciences Limited |
Novel substituted sulfoximine compounds
|
|
JP7412328B2
(ja)
|
2017-07-24 |
2024-01-12 |
ノバルティス アーゲー |
Ｎｌｒｐ活性に関連する状態を治療するための化合物及び組成物
|
|
WO2019034697A1
(en)
|
2017-08-15 |
2019-02-21 |
Inflazome Limited |
NOVEL CARBOXAMIDE SULFONAMIDE COMPOUNDS
|
|
MA53172A
(fr)
|
2018-07-20 |
2021-05-26 |
Hoffmann La Roche |
Composés de sulfonimidamide en tant qu'inhibiteurs de l'activité de l'interleukine 1
|
|
GB201902327D0
(en)
|
2019-02-20 |
2019-04-03 |
Inflazome Ltd |
Novel compounds
|
|
PY1975819A
(es)
|
2018-09-13 |
2020-04-09 |
Bayer Ag |
Derivados heterocíclicos como plaguicidas.-
|
|
WO2020150674A1
(en)
|
2019-01-18 |
2020-07-23 |
Nuvation Bio Inc. |
Heterocyclic compounds as adenosine antagonists
|
|
CN114008030A
(zh)
|
2019-06-21 |
2022-02-01 |
Ac免疫有限公司 |
用作nlrp3调节剂的稠合的1,2-噻唑和1,2-噻嗪
|